SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,590,000 | -9.9% | 353,603 | -36.3% | 0.18% | -17.3% |
| Q3 2020 | $33,951,000 | +45.2% | 555,473 | -1.2% | 0.22% | +36.6% |
| Q2 2020 | $23,387,000 | +90.8% | 562,457 | +31.8% | 0.16% | +49.1% |
| Q1 2020 | $12,255,000 | -31.3% | 426,692 | +72.6% | 0.11% | -15.0% |
| Q4 2019 | $17,846,000 | -13.4% | 247,209 | +68.2% | 0.13% | -23.0% |
| Q3 2019 | $20,617,000 | – | 146,961 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |